Literature DB >> 26897338

Molecular and immunological analysis of hen's egg yolk allergens with a focus on YGP42 (Gal d 6).

Chamika De Silva1, Pathum Dhanapala2, Tim Doran3, Mimi L K Tang4, Cenk Suphioglu5.   

Abstract

Allergy to hen's (Gallus domesticus) egg white is one of the most common forms of food allergy. Allergy to hen's yolk also exists however, to a lesser extent when compared to egg white allergy. Two minor allergens from the hen's egg yolk known as α-livetin (Gal d 5) and YGP42 (Gal d 6) were discovered recently. In this study, we investigated whether sensitization to egg white is associated with reactivity to egg yolk as well. Sera obtained from 25 patients with allergy to egg white were tested for specific IgE binding for egg yolk proteins through western immunoblotting. 36% of patients were found with true IgE-sensitization against egg yolk proteins. It was found that most of the IgE reactive yolk proteins were fragments of major precursor proteins of hen; vitellogenin-1 (VTG-1), vitellogenin-2 (VTG-2) and apolipoprotein B (Apo B). The egg yolk allergen Gal d 6 is the C-terminal part of VTG-1 and was found to be allergenic in significant percentage of egg white allergy patients. These results highlight the significance of Gal d 6 as an important allergen of egg yolk. Therefore, the secondary aim of this study involved developing a recombinant version of YGP42 in an Escherichia coli expression system. Recombinant Gal d 6 (rGal d6) was expressed as a fusion peptide with a 6 × His tag and purified using metal chelating resin. The inhibition ELISA results showed that rYGP42 was IgE reactive and was able to inhibit IgE binding to crude egg yolk (CEY) by up to 30%. Traditionally, it was thought that allergy to egg yolk occurred independently from sensitization to egg white. This study underlies the importance of concomitant sensitization to egg yolk proteins in patients allergic to egg white. Evidence reported in this study strongly suggests that egg yolk has potentially undiscovered allergens and therefore warrants further investigation. Furthermore, IgE reactive Gal d 6 presented in this study has the potential to be used in diagnosis and immunotherapy to treat egg allergy.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Allergen specific immunotherapy; Allergy; Egg yolk allergens; Recombinant allergens

Mesh:

Substances:

Year:  2016        PMID: 26897338     DOI: 10.1016/j.molimm.2016.02.005

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

Review 1.  WHO/IUIS Allergen Nomenclature: Providing a common language.

Authors:  Anna Pomés; Janet M Davies; Gabriele Gadermaier; Christiane Hilger; Thomas Holzhauser; Jonas Lidholm; Andreas L Lopata; Geoffrey A Mueller; Andreas Nandy; Christian Radauer; Sanny K Chan; Uta Jappe; Jörg Kleine-Tebbe; Wayne R Thomas; Martin D Chapman; Marianne van Hage; Ronald van Ree; Stefan Vieths; Monika Raulf; Richard E Goodman
Journal:  Mol Immunol       Date:  2018-04-04       Impact factor: 4.407

Review 2.  Review of New Trends in the Analysis of Allergenic Residues in Foods and Cosmetic Products.

Authors:  Tomasz Tuzimski; Anna Petruczynik
Journal:  J AOAC Int       Date:  2020-07-01       Impact factor: 1.913

3.  IL-2-Agonist-Induced IFN-γ Exacerbates Systemic Anaphylaxis in Food Allergen-Sensitized Mice.

Authors:  Christopher W M Link; Christina N Rau; Christopher C Udoye; Mohab Ragab; Rabia Ü Korkmaz; Sara Comdühr; Ann-Katrin Clauder; Timo Lindemann; Britta Frehse; Katharina Hofmann; Larissa N Almeida; Yves Laumonnier; Asmaa El Beidaq; Fred D Finkelman; Rudolf A Manz
Journal:  Front Immunol       Date:  2020-12-11       Impact factor: 7.561

4.  Immunological Comparison of Native and Recombinant Hen's Egg Yolk Allergen, Chicken Serum Albumin (Gal d 5), Produced in Kluveromyces lactis.

Authors:  Chamika De Silva; Pathum Dhanapala; Samuel King; Timothy Doran; Mimi Tang; Cenk Suphioglu
Journal:  Nutrients       Date:  2018-06-12       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.